{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:16:30Z","timestamp":1791832590243,"version":"4.3.4"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,5,29]]},"DOI":"10.18632\/aging.103164","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T15:51:10Z","timestamp":1590767470000},"page":"9031-9040","source":"Crossref","is-referenced-by-count":18,"title":["Role of Citicoline in an in vitro AMD model"],"prefix":"10.18632","volume":"12","author":[{"given":"Sonali","family":"Nashine","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Kenney","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA 92697, USA"},{"name":"Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues.","volume":"2","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"2","first-page":"17","article-title":"Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.","volume":"9","author":"Schauss","year":"2004","journal-title":"Altern Med Rev"},{"key":"3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.bbalip.2012.09.009","article-title":"Phosphatidylcholine and the CDP-choline cycle.","volume":"183","author":"Jackowski","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/CIA.S87886","article-title":"The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.","volume":"1","author":"Bruni","year":"2015","journal-title":"Clin Interv Aging"},{"key":"5","first-page":"489","article-title":"Citicoline in the treatment of parkinson\u2019s disease.","volume":"1","author":"Traegner","year":"1990","journal-title":"Clin Ther"},{"key":"6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","article-title":"Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (Citicoline): a study of 8 years of follow-up.","volume":"11","author":"Parisi","year":"2005","journal-title":"Doc Ophthalmol"},{"key":"7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0079-6123(08)01137-0","article-title":"Evidence of the neuroprotective role of citicoline in glaucoma patients.","volume":"17","author":"Manni","year":"2008","journal-title":"Prog Brain Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000350496","article-title":"Citicoline oral solution in glaucoma: is there a role in slowing disease progression?","volume":"22","author":"Rossetti","year":"2013","journal-title":"Ophthalmologica"},{"key":"9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0161-6420(99)90269-5","article-title":"Cytidine-5'-diphosphocholine (Citicoline) improves retinal and cortical responses in patients with glaucoma.","volume":"10","author":"Bucci","year":"1999","journal-title":"Ophthalmology"},{"key":"10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1358\/mf.2009.31.3.1364241","article-title":"Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.","volume":"3","author":"Kim","year":"2009","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/CIA.S38420","article-title":"Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.","volume":"8","author":"Gareri","year":"2013","journal-title":"Clin Interv Aging"},{"key":"12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0024-3205(94)00427-t","article-title":"Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.","volume":"5","author":"Weiss","year":"1995","journal-title":"Life Sci"},{"key":"13","doi-asserted-by":"publisher","first-page":"e0159828","DOI":"10.1371\/journal.pone.0159828","article-title":"Differential expression of complement markers in normal and AMD transmitochondrial cybrids.","volume":"1","author":"Kenney","year":"2016","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"publisher","first-page":"e2951","DOI":"10.1038\/cddis.2017.348","article-title":"Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage.","volume":"8","author":"Kenney","year":"2017","journal-title":"Cell Death Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"15175","DOI":"10.1038\/s41598-018-33290-5","article-title":"Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration.","volume":"8","author":"Kenney","year":"2018","journal-title":"Sci Rep"},{"key":"16","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/s110201744","article-title":"Sensing phosphatidylserine in cellular membranes.","volume":"1","author":"Grinstein","year":"2011","journal-title":"Sensors (Basel)"},{"key":"17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/AAC.02591-12","article-title":"Potential efficacy of citicoline as adjunct therapy in treatment of cerebral malaria.","volume":"5","author":"Jambou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"18","doi-asserted-by":"publisher","first-page":"a008714","DOI":"10.1101\/cshperspect.a008714","article-title":"Mechanisms of action of bcl-2 family proteins.","volume":"5","author":"Andrews","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis.","volume":"6","author":"J\u00e4nicke","year":"1999","journal-title":"Cell Death Differ"},{"key":"20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1357-2725(99)00024-2","article-title":"Caspase-9.","volume":"3","author":"Kuida","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2018.10.034","article-title":"A novel role for Bcl2l13 in promoting beige adipocyte biogenesis.","volume":"50","author":"Jia","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/jnc.12269","article-title":"Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.","volume":"12","author":"Lizasoain","year":"2013","journal-title":"J Neurochem"},{"key":"23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0306-4522(02)00912-0","article-title":"Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia.","volume":"11","author":"Roda","year":"2003","journal-title":"Neuroscience"},{"key":"24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/s0028-3908(02)00032-1","article-title":"CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat.","volume":"4","author":"Lozano","year":"2002","journal-title":"Neuropharmacology"},{"key":"25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1358\/mf.1999.21.8.794835","article-title":"Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats.","volume":"2","author":"Cacabelos","year":"1999","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"26","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.3390\/ijms15046286","article-title":"Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration.","volume":"1","author":"Malchiodi-Albedi","year":"2014","journal-title":"Int J Mol Sci"},{"key":"27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2005.12.128","article-title":"Action of citicoline on rat retinal expression of extracellular-signal-regulated kinase (ERK1\/2).","volume":"108","author":"Cho","year":"2006","journal-title":"Brain Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/ijms19082458","article-title":"Effects of liposomal formulation of citicoline in experimental diabetes-induced retinal neurodegeneration.","volume":"1","author":"Hern\u00e1ndez","year":"2018","journal-title":"Int J Mol Sci"},{"key":"29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/BF00965041","article-title":"Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil.","volume":"6","author":"Porcellati","year":"1981","journal-title":"Neurochem Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jnr.10672","article-title":"Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia.","volume":"7","author":"Hatcher","year":"2003","journal-title":"J Neurosci Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.18632\/aging.102179","article-title":"PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics.","volume":"1","author":"Kenney","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.18632\/aging.101820","article-title":"Nutraceutical effects of Emblica officinalis in age-related macular degeneration.","volume":"1","author":"Kenney","year":"2019","journal-title":"Aging (Albany NY)"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:23:34Z","timestamp":1599078214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,31]]}},"alternative-id":["103164","32470946"],"URL":"https:\/\/doi.org\/10.18632\/aging.103164","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}